Sep 13, 2022 / 08:40PM GMT
Alberto Bertani - Morgan Stanley - MD
All right. Well, thanks, everyone, for joining us today. It's Alberto Bertani from Morgan Stanley banking team. And it's my pleasure to host Lindon Robertson, CFO of Azenta; and Matt McManus, Chief Operating Officer. Thank you very much.
For important disclosures, please see Morgan Stanley Research Disclosure website at morganstanleyresearchdisclosures.com (sic) [morganstanley.com/researchdisclosures]. If you have any questions, please reach out to your Morgan Stanley sales representative.
So in terms of kicking off the discussion, can you give us sort of 10 minutes overview of the strategy of Azenta history as a life science company? That would be helpful.
Lindon G. Robertson - Azenta, Inc. - Executive VP & CFO
Yes, that would be great. So we're in our first year as a life science company, but in about our 40th year as being a company. And so we've gone through a transition -- transformation out of 2021 as we separated a company that was born in the semiconductor space and we launched as a new life
Azenta Inc at Morgan Stanley Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot